Home » Topics » Regulatory » Health Canada

Health Canada
RSS

New safety information for Zofran issued in Canada

Oct. 10, 2012

Apricus Biosciences plans Canadian submission for MycoVa

Oct. 2, 2012

Health Canada approves Dermagraft for diabetic foot ulcers

Sep. 7, 2012

Health Canada approves Treanda

Aug. 29, 2012

Tarceva approved in Canada for specific NSCLC subtype

Aug. 14, 2012

Xiaflex approved in Canada

July 10, 2012

TONIX reports encouraging pharmacokinetic data on TNX-102

July 10, 2012

Health Canada approves Jakavi for treatment of patients with myelofibrosis

July 6, 2012

Optimer obtains approval in Canada for CDI treatment

July 6, 2012

Theratechnologies gives update on tesamorelin regulatory progress

June 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 31, 2025
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Marks’ departure intensifies regulatory uncertainty at US FDA
BioWorld
Peter Marks’ March 28 letter giving one week’s notice of his resignation as director of the U.S. FDA’s Center for Biologics Evaluation and Research (CBER) is...